Daejin Advanced Materials대진첨단소재

Daejin Advanced Materials is loss-making and heavily indebted, with its shares down about 63% over the past year.

The company reported trailing twelve-month revenue of about ₩105B for the half year to June 2026, but operating and net losses were much larger, at roughly -₩22B and -₩33B. Liabilities are well above equity, cash is small against ₩58B of borrowings, and the shares trade at ₩2,825 after a 52-week range of ₩2,340 to ₩8,370. The filings in the data show a pending merger decision and several market-status notices, but the data does not explain their terms or outcome.

What stands out

• Trailing revenue is about ₩105B, but the operating margin is -21.3% and the net margin is -31.3%.
• Borrowings of about ₩58B compare with cash of about ₩1.1B, and liabilities are 151.6% of equity.
• Full-year 2025 revenue fell about 5% to ₩85B, and the net loss widened to about ₩38B from a small loss in 2024.
• Recent filings include two merger decisions dated 1 October 2026, a trading halt and a delisting notice from July 2026, and an investment caution designation in August 2026.
• Its only headline in the data is about a technology leak trial in which the CEO is reported to be explaining the facts.

What to watch

• The terms, timing and outcome of the merger decision, which the data does not describe.
• The next periodic results and whether the auditor's opinion or capital impairment issues are resolved, since the August filing mentions an adverse opinion and capital impairment of 50% or more.
• Developments in the technology leak trial and any effect on the company's operations or listing status.